Women and lung cancer: Clinical and molecular profiling as a determinate for treatment decisions A literature review

被引：10
作者：
Berardi, Rossana [1 ]
Verdecchia, Lorena [1 ]
Paolo, Marzia Di Pietro [1 ]
Giampieri, Riccardo [1 ]
Scartozzi, Mario [1 ]
Pierantoni, Chiara [1 ]
Bianconi, Maristella [1 ]
Mazzanti, Paola [1 ]
Cascinu, Stefano [1 ]
机构：
[1] Univ Politecn Marche, Azienda Osped, Univ Osped Riuniti Umberto I, GM Lancisi,G Salesi,Clin Oncol Med, I-60020 Ancona, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 69卷 / 03期
关键词：
Lung cancer; NSCLC Women; Molecular biology; Target therapies; ENVIRONMENTAL TOBACCO-SMOKE; RANDOMIZED PHASE-II; PREVIOUSLY TREATED PATIENTS; VINORELBINE PLUS CISPLATIN; ENDOTHELIAL GROWTH-FACTOR; ESTROGEN-RECEPTOR-ALPHA; GENETIC POLYMORPHISMS; REPLACEMENT THERAPY; C-ERBB-2; EXPRESSION; MONOCLONAL-ANTIBODY;
D O I：
10.1016/j.critrevonc.2008.06.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In the past decade the incidence of lung cancer among women has risen, whereas among men it has slightly declined. Important differences in lung cancer have been demonstrated between men and women, although many areas still remain controversial. Some biologic differences may justify the increase in response of women to therapy for lung cancer and can partially explain the improved survival of women compared with men. We extensively reviewed the published scientific literature on this topic in order to investigate the clinical and genetic profiling underlying lung cancer in women and to use this information as a tool for medical therapy. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：223 / 236
页数：14
相关论文
共 118 条
[1]  
ALBAIN KS, 2007, P ASCO 1, pS18
[2]   Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke [J].
Anderson, KE ;
Carmella, SG ;
Ye, M ;
Bliss, RL ;
Le, C ;
Murphy, L ;
Hecht, SS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (05) :378-381
[3]  
[Anonymous], J CLIN ONCOL S
[4]  
Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3
[5]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[6]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[7]  
Behera D, 2005, J Assoc Physicians India, V53, P190
[8]   Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender [J].
Belani, C ;
von Pawel, J ;
Pluzanska, A ;
Gorbounova, V ;
Kaukel, E ;
Mattson, K ;
Ramlau, R ;
Fidias, P ;
Millward, M ;
Fossella, F .
LUNG CANCER, 2005, 49 :S235-S236
[9]   Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk [J].
Benhamou, S ;
Lee, WJ ;
Alexandrie, AK ;
Boffetta, P ;
Bouchardy, C ;
Butkiewicz, D ;
Brockmöller, J ;
Clapper, ML ;
Daly, A ;
Dolzan, V ;
Ford, J ;
Gaspari, L ;
Haugen, A ;
Hirvonen, A ;
Husgafvel-Pursiainen, K ;
Ingelman-Sundberg, M ;
Kalina, I ;
Kihara, M ;
Kremers, P ;
Le Marchand, L ;
London, SJ ;
Nazar-Stewart, V ;
Onon-Kihara, M ;
Rannug, A ;
Romkes, M ;
Ryberg, D ;
Seidegard, J ;
Shields, P ;
Strange, RC ;
Stücker, I ;
To-Figueras, J ;
Brennan, P ;
Taioli, E .
CARCINOGENESIS, 2002, 23 (08) :1343-1350
[10]   Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women [J].
Bennett, WP ;
Alavanja, MCR ;
Blomeke, B ;
Vähäkangas, KH ;
Castrén, K ;
Welsh, JA ;
Bowman, ED ;
Khan, MA ;
Flieder, DB ;
Harris, CC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) :2009-2014
12345678910